Skip to main content
. Author manuscript; available in PMC: 2009 Oct 27.
Published in final edited form as: J Gerontol A Biol Sci Med Sci. 2008 Dec;63(12):1410–1415. doi: 10.1093/gerona/63.12.1410

Table 3.

Association of Depression and Antidepressant Use With Lower Spine Bone Mineral Density (g/cm2) Stratified by Sex

Model 1
Model 2
Model 3
Variable Coefficient
(95% CI)
p Value Coefficient
(95% CI)
p Value Coefficient
(95% CI)
p Value
Women
 Lifetime MDD (ref. Never) −0.180
(−0.299, −0.060)
.003 −0.132
(−0.244, −0.021)
.020 −0.162
(−0.285, −0.039)
.010
 Lifetime antidepressant use (ref. Never use) −0.156
(−0.266, −0.047)
.005 −0.141
(−0.263, −0.020)
.023
Men
 Lifetime MDD (ref. Never) 0.005
(−0.157, 0.166)
.955 −0.035
(−0.205, 0.136)
.691 −0.106
(−0.267, 0.056)
.199
 Lifetime antidepressant use (ref. Never use) 0.094
(−0.087, 0.274)
.308 0.073
(−0.086, 0.232)
.366

Notes: For women (N = 63): Model 1 is adjusted for age and race. Model 2 is adjusted for Model 1 plus lifetime antidepressant use. Model 3 is adjusted for Model 2 plus calcium use, total percent fat, and lifetime estrogen use. For men (N = 31): Model 1 is adjusted for age and race. Model 2 is adjusted for Model 1 plus lifetime antidepressant use. Model 3 is adjusted for Model 2 plus smoking status, alcohol use, Physical Activity Scale for the Elderly score, and total percent fat.

CI = confidence interval; MDD = major depressive disorder.

HHS Vulnerability Disclosure